id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id FDA-2009-E-0510-0015,FDA,FDA-2009-E-0510,U.S. Patent and Trademark Office to Novartis - Letter,Other,Letter(s),2013-05-07T04:00:00Z,2013,5,2013-05-07T04:00:00Z,,2013-05-07T16:31:58Z,,0,0,09000064812bdea4 FDA-2009-E-0510-0014,FDA,FDA-2009-E-0510,Notice of Final Determination - Letter,Other,Letter(s),2012-12-17T05:00:00Z,2012,12,2012-12-17T05:00:00Z,,2012-12-17T17:22:32Z,,0,0,090000648118fc0f FDA-2009-E-0510-0013,FDA,FDA-2009-E-0510,FDA/CDER to U.S. Patent Trademark Office - Letter,Other,Letter(s),2011-08-15T04:00:00Z,2011,8,2011-08-15T04:00:00Z,,2011-08-15T19:15:47Z,,0,0,0900006480ee11a4 FDA-2009-E-0510-0012,FDA,FDA-2009-E-0510,Determination of Regulatory Review Period for Purposes of Patent Extension: COARTEM,Notice,N-Notice,2010-12-10T05:00:00Z,2010,12,2010-12-10T05:00:00Z,,2024-11-07T22:28:12Z,2010-31074,1,0,0900006480bb3967 FDA-2009-E-0510-0011,FDA,FDA-2009-E-0510,U.S. Patent and Trademark Office to the FDA/CDER - Letter,Other,LET-Letter,2010-04-21T04:00:00Z,2010,4,2010-04-21T04:00:00Z,,2013-07-27T23:16:24Z,,0,0,0900006480adc3e7 FDA-2009-E-0510-0008,FDA,FDA-2009-E-0510,FDA/CDER to U.S. Patent and Trademark Office - Letter,Other,LET-Letter,2010-02-18T05:00:00Z,2010,2,2010-02-18T05:00:00Z,,2013-07-27T23:08:47Z,,0,0,0900006480aa72bb FDA-2009-E-0510-0010,FDA,FDA-2009-E-0510,Novartis - Supplemental Patent Term Extension Application,Other,APP-Application,2010-02-18T05:00:00Z,2010,2,2010-02-18T05:00:00Z,,2013-07-27T23:04:49Z,,0,0,0900006480a80810 FDA-2009-E-0510-0009,FDA,FDA-2009-E-0510,U.S. Patent & Trademark Office to FDA/CDER - Letter,Other,LET-Letter,2010-02-18T05:00:00Z,2010,2,2010-02-18T05:00:00Z,,2013-07-27T23:04:49Z,,0,0,0900006480a8080e FDA-2009-E-0510-0004,FDA,FDA-2009-E-0510,Novartis - Patent Term Extension Application - Appendix B,Supporting & Related Material,APP-Application,2009-10-16T04:00:00Z,2009,10,,,2009-10-16T13:53:51Z,,0,0,0900006480a43293 FDA-2009-E-0510-0003,FDA,FDA-2009-E-0510,Novartis - Patent Term Extension Application - Appendix A,Supporting & Related Material,APP-Application,2009-10-16T04:00:00Z,2009,10,,,2009-10-16T13:53:50Z,,0,0,0900006480a43290 FDA-2009-E-0510-0005,FDA,FDA-2009-E-0510,Novartis - Patent Term Extension Application - Appendix C,Supporting & Related Material,APP-Application,2009-10-16T04:00:00Z,2009,10,,,2009-10-16T13:53:52Z,,0,0,0900006480a43318 FDA-2009-E-0510-0001,FDA,FDA-2009-E-0510,U.S. Patent and Trademark Office to FDA/CDER - Letter,Other,LET-Letter,2009-10-16T04:00:00Z,2009,10,2009-10-16T04:00:00Z,,2009-10-16T13:53:38Z,,0,0,0900006480a4328a FDA-2009-E-0510-0007,FDA,FDA-2009-E-0510,Novartis - Patent Term Extension Application - Appendix E,Supporting & Related Material,APP-Application,2009-10-16T04:00:00Z,2009,10,,,2009-10-16T13:53:55Z,,0,0,0900006480a4331d FDA-2009-E-0510-0002,FDA,FDA-2009-E-0510,Novartis - Patent Term Extension Application,Other,APP-Application,2009-10-16T04:00:00Z,2009,10,2009-10-16T04:00:00Z,,2013-07-27T22:57:11Z,,0,0,0900006480a4328d FDA-2009-E-0510-0006,FDA,FDA-2009-E-0510,Novartis - Patent Term Extension Application - Appendix D,Supporting & Related Material,APP-Application,2009-10-16T04:00:00Z,2009,10,,,2009-10-16T13:53:53Z,,0,0,0900006480a4331b